CVR 45653439Public limited company (A/S)Engroshandel med medicinalvarer og sygeplejeartikler (464610)LøgstørFounded 3 Jun 2025
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about PharmaService A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEmployees
35
CVR registry, Aug 2026
+2 (+6.1%) over 12 months
Revenue
291.8M
DKK, annual report 2025
Result
+5M
DKK, annual report 2025
Equity
5.4M
DKK, annual report 2025
PHIdeer ApSCVR 45642836, 33.3% to under 50% of capital and votes, since 3 Jun 2025
MOMBO Holding ApSCVR 45643026, 33.3% to under 50% of capital and votes, since 3 Jun 2025
and 1 moreMargarethe Bowersince 3 Jun 2025
CVR 4564283633.3% to under 50% of capital and votessince 3 Jun 2025
CVR 4564302633.3% to under 50% of capital and votessince 3 Jun 2025
CVR 4564594033.3% to under 50% of capital and votessince 3 Jun 2025
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
3 Jun 2025 to 4 Nov 2026.
| Metric | 2025 |
|---|---|
| Revenue | 291,776 |
| Operating profit | +12,755 |
| Result for the year | +4,980 |
| Equity | 5,380 |
| Total assets | 298,349 |
| Employees (average) | 29 |
| Credit metrics (Dandex calculations) | |
| EBIT margin (overskudsgrad) | 4.4% |
| EBITDA | 17,012 |
| EBITDA margin | 5.8% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | 26,293 |
| Capex (investeringer i anlægsaktiver) | 76,317 |
| Capex % of sales (investeringer i procent af omsætningen) | 26.2% |
| FCFF / EBITDA (pengestrømskonvertering) | -129.7% |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 178,653 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. 2025 covers 7 months (3 Jun to 31 Dec 2025).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions.
Annual report 2025
3 Jun 2025 to 31 Dec 2025, published 28 Jun 2026
1 registration, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Stiftelsesdato: 03.06.2025.
Virkningsdato: 03.06.2025.
Seneste vedtægtsdato: 03.06.2025.
Kapital:
kr. 400.002,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 400.002,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
CVR-NR. 45642836 PHIdeer ApS, c/o Pharmaservice I/S, Limfjordsvej 9, 9670 Løgstør, den 03.06.2025, CVR-NR. 45643026 MOMBO Holding ApS, c/o Margarethe Bower, Skjoldhøj Alle 3, 2920 Charlottenlund, den 03.06.2025, CVR-NR. 45645940 PEHASI DK ApS, c/o Pharmaservice I/S, Limfjordsvej 9, 9670 Løgstør, den 03.06.2025.
Bestyrelse:
Hans Christian Graversen, (formand), den 03.06.2025, Margarethe Bower, den 03.06.2025, Peter Graversen, den 03.06.2025.
Direktion:
Margarethe Bower, den 03.06.2025.
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening.
Revision:
CVR-NR. 15915641 CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB, Østbanegade 123, 2100 København Ø, den 03.06.2025.
Første regnskabsår:
03.06.2025 - 31.12.2025.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at drive engroshandel med medicinalvarer og sygeplejeartikler, herunder importvirksomhed, agentur og evt. produktion af lægemidler eller dermed beslægtede varer.
1 registered in CVR.
P-number 1031387910Limfjordsvej 9, 9670 Løgstør
